BioSpace News Archive

Spectrum Dynamics, a global leader, developer, manufacturer and seller of specialized SPECT cardiac imaging equipment, filed a lawsuit today against GE for theft and misappropriation of Spectrum Dynamics’ trade secrets and intellectual property in the United States District Court for the Southern District of New York.

The Board of Directors for The Villages Health is pleased to announce the appointment of Bob Trinh as its new Chief Executive Officer.

Baptist Health International announces the opening of its first PET and CT Imaging Center in Grand Cayman, Cayman Islands. Equipped with state-of-the-art positron emission tomography (PET) and computerized tomography (CT) technology, the center will transform the Cayman Islands into a medical destination.

Aptorum Group Limited today announced that on December 3, 2018, its registration statement on Form F-1, relating to a proposed initial public offering of its Class A Ordinary Shares, par value US$1.00 per share, at a price to the public of $15.80 per share, for gross proceeds of a minimum of US$10 million and up to US$30 million, has been declared effective by the U.S. Securities and Exchange Commission.

Report finds nearly one in 10 Americans live in a home with a loaded and unlocked gun

A new clinical trial finds that many patients who were treated for iron deficiency anemia with ferric carboxymaltose showed persistent hypophosphatemia five weeks after receiving the treatment.

Bankers Healthcare Group, a leading provider of financial solutions for healthcare professionals, has been named a best place to work for diversity by Great Place to Work and FORTUNE magazine.

Janne Huhtala, CEO of MEGIN, a manufacturer of magnetoencephalography (MEG) technology for functional brain imaging, spoke about the future innovation of MEG technology during the Fifth Annual G20 World Brain Mapping Summit/Neuroscience 20.

PharmaForce International’s newest study, Competitive Benchmarking of Leading Diabetes Sales and Marketing Organizations in Japan, benchmarks leading diabetes organizations in Japan

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the quarter ended Oct. 31, 2018.